Entasis Therapeutics Holdings
Latest round
- Series B
Last raised
- Sep 2017
Total raised
- $82M
Investors
- 7
About Entasis Therapeutics Holdings
Entasis Therapeutics Holdings Inc.Founded in 2015 and headquartered in Waltham, US, Entasis Therapeutics specializes in developing treatments for serious infections. The company has not undergone any significant pivots or changes in its business strategy. Manos Perros serves as both the CEO and the founder, bringing prior experience in the pharmaceutical industry.Entasis Therapeutics is dedicated to addressing critical care and infectious diseases through its innovative product offerings. Key products include the antibiotic therapies designed for treating complicated infections caused by drug-resistant bacteria, with a focus on healthcare providers managing serious medical conditions.In its most recent financial year, Entasis Therapeutics reported zero revenue. The company is also looking to expand into additional markets within Europe and Asia by 2023, aiming to enhance access to its therapies.
Who invested in Entasis Therapeutics Holdings
7 investors across 2 rounds
See all investors in Entasis Therapeutics Holdings
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Entasis Therapeutics Holdings
Who invested in Entasis Therapeutics Holdings?
Entasis Therapeutics Holdings has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Entasis Therapeutics Holdings raised?
Entasis Therapeutics Holdings has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Entasis Therapeutics Holdings last raise money?
Entasis Therapeutics Holdings's most recent round on record is a Series B, in Sep 2017.
What does Entasis Therapeutics Holdings do?
Entasis Therapeutics Holdings Inc.
Where is Entasis Therapeutics Holdings headquartered?
Entasis Therapeutics Holdings is headquartered in Waltham, US.
Which VCs invest in companies like Entasis Therapeutics Holdings?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Entasis Therapeutics Holdings's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Entasis Therapeutics Holdings? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.